Optimal Synthesis of Benzodiazepine Glucuronide

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$234,280.00
Award Year:
1995
Program:
SBIR
Phase:
Phase II
Contract:
N/A
Agency Tracking Number:
22429
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Synthetic Technology
3615 Harding Ave., Suite 304, Honolulu, HI, 96816
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 Xue-Qin Gu
 (808) 734-0422
Business Contact
Phone: () -
Research Institution
N/A
Abstract
Benzodiazepines are in clinical use as antianxiety agents and are controlled substances. Prolonged use may be habit forming. Benzodiazepine abuse is a widespread problem. There is a practical need to screen for the presence of benzodiazepines and their metabolites. Oxazepam glucuronide is the final metabolite of oxazepam and related benzodiazepines in humans and other species. It may be used in the area of drug screening to establish a protocol which will be simpler, faster and more reliable than the method in current use which requires a hydrolysis step. This project proposes to explore the chemical synthesis of oxazepam glucuronide. The synthesis research will include a. preparation of the proper protected sugar moieties, b. coupling reactions between oxazepam and the protected sugar moieties, and c. conversion of coupling compounds into oxazepam glucuronide. The success of the proposed project will provide a new commercial product for forensic chemistry and will lead to the establishment of a new testing method which will have obvious advantages over the present hydrolysis- extraction method. The knowledge from the successful research will be useful for the synthesis of glucuronides of benzodiazepines and other drugs.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government